Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05526352 · ClinicalTrials.gov registry record
@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
A clinical trial of Intracranial Aneurysm, sponsored by University Hospital, Geneva.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 20
- Study locations
NCT05526352: Recruiting study of Intracranial Aneurysm, sponsored by University Hospital, Geneva.
NCT05526352 is a study of Intracranial Aneurysm that is actively recruiting participants, run by University Hospital, Geneva. The registered enrollment target is 20,000 participants, above the 7,768-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (157% higher). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05526352, a study of Intracranial Aneurysm, is actively recruiting participants, sponsored by University Hospital, Geneva.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary aim of the SwissNeuroFoundation AneurysmDataBase Project is to implement information technology based tools to create and use a holistic reference database specific to intracranial aneurysms (IA). The SwissNeuroFoundation AneurysmDataBase are concerned with generating the data with which to populate this database. The purpose for populating the database are to: * Screen for and evaluate markers of risk for intracranial aneurysm formation and aneurysm rupture. Are considered as markers the following: genetics factors, microbiota, environmental factors, congenital factors (ie: cerebrovascular anatomical variants), transcriptomics signature, proteomics signature,shape characteristics, haemodynamics characteristics. * Screen for and evaluate prognostic factors of outcome regarding different management strategies including watchful observation, microsurgical treatment, endovascular treatment or any combination thereof. * Implement and evaluate patient-specific management protocols integrating all available information. * Evaluate the impact of the database and use of tools to improve care, reduce costs, support knowledge discovery and promote new industrial developments.
Primary Outcome
Validation and improvement of the holistic disease model
Conditions Studied
Study Locations (20)
Other
- Montreal Neurological Institute and Hospital, McGill University - Montreal
- Helsinki University Central Hospital - Helsinki
- Kuopio University Hospital - Kuopio
- ICAN - Nantes
- Department of Neurosurgery, Klinikum rechts der Isar, Technical University Munich - Munich
- University of Pecs - Pécs
- Erasmus Medical Center - Rotterdam
- University Medical Center Utrecht - Utrecht
- Jagiellonian University Medical College - Krakow
- Barcelona Hospital General de Cataluna - Barcelona
- Hospital Clinic Barcelona - Barcelona
- IMIM - Hospital del Mar - Barcelona
- Neurochirurgie / Hôpitaux Universitaire de Genève - Geneva
- University Hospital of Lausanne (CHUV), CoLaus Datacenter - Lausanne
- Department of Neurosurgery, Cantonal Hospital St. Gallen - Sankt Gallen
- Klinik Hirslanded - Zurich
- University College London - London
California
- University of California - San Francisco
Ohio
- University of Cincinnati College of Medicine - Cincinnati
Virginia
- University of Virginia - Virginia Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2015-06-01 |
| Est. Completion | 2040-03-01 |
What NCT05526352 shows while recruiting
NCT05526352 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 7,768-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (157% higher).
The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 0 interventions.
NCT05526352 names 20 study sites across 4 states, led by Other, California, Ohio.
Frequently Asked Questions
What is clinical trial NCT05526352 about?
NCT05526352 is a clinical study titled "@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms". The primary aim of the SwissNeuroFoundation AneurysmDataBase Project is to implement information technology based tools to create and use a holistic reference database specific to intracranial aneurysms (IA). The SwissNeuroFoundation AneurysmDataBase are concerned with generating the data with whic...
What is the current status of trial NCT05526352?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2015-06-01. Estimated completion is 2040-03-01.
What conditions does trial NCT05526352 study?
This clinical trial studies the following conditions: Intracranial Aneurysm.
Who is sponsoring clinical trial NCT05526352?
This trial is sponsored by University Hospital, Geneva, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05526352 being conducted?
This trial has 20 study locations across California, Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05526352's enrollment target sits among peer trials
20,000 2nd of 14 the highest of 14 other Intracranial Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracranial Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Product Surveillance Registry
RECRUITING
-
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
RECRUITING
-
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
RECRUITING
-
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
RECRUITING
-
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
RECRUITING · NA
-
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI